InsiderTrades

Form 4 for CVRX CVRx, Inc.

Accepted 2021-07-02 00:00:00 ET · period of report 2021-07-02 · accession 0001179110-21-007339 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DI 2021-07-02 2021-07-02 CVRX Pardo Geoffrey B Dir C - Cnv Deriv — +1.55M 1.55M New —
DI 2021-07-02 2021-07-02 CVRX Pardo Geoffrey B Dir P - Purchase $18.00 +275.0K 1.83M +18% +$4.95M
DI 2021-07-02 2021-07-02 CVRX Pardo Geoffrey B Dir C - Cnv Deriv $0.00 -24.58M 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-07-02 C A 1,554,022 — 1,554,022 I See Footnote — — (F1) Upon the closing of the Issuer's initial public offering, each share of Series G Convertible Preferred Stock automatically converted into shares of common stock at a rate of 1-for-0.0632143218. (F2) These shares are held directly by Cooperatieve Gilde Healthcare IV U.A. ("Gilde IV"). The Reporting Person is a partner of Gilde IV and may be deemed to share voting and dispositive over the shares held by Gilde IV. The Reporting Person disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares.
2 Common Common Stock 2021-07-02 P A 275,000 $18.00 1,829,022 I See Footnote — — (F2) These shares are held directly by Cooperatieve Gilde Healthcare IV U.A. ("Gilde IV"). The Reporting Person is a partner of Gilde IV and may be deemed to share voting and dispositive over the shares held by Gilde IV. The Reporting Person disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares.
3 Derivative Series G Preferred Stock 2021-07-02 C D 24,583,397 $0.00 0 I See Footnote — · — to — 1,554,022 Common Stock (F2) These shares are held directly by Cooperatieve Gilde Healthcare IV U.A. ("Gilde IV"). The Reporting Person is a partner of Gilde IV and may be deemed to share voting and dispositive over the shares held by Gilde IV. The Reporting Person disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares. (F1) Upon the closing of the Issuer's initial public offering, each share of Series G Convertible Preferred Stock automatically converted into shares of common stock at a rate of 1-for-0.0632143218. (F3) Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of common stock at the then-appliable conversion rate for no additional consideration (subject to the payment of cash in lieu of any fractional shares). The conversion rates reported reflect the conversion ratios under the Issuer's certificate of incorporation, adjusted to give effect to the previously effected 1-for-39.548 reverse stock split of the common stock.